| Treatment of T1N0 Invasive Breast Carcinoma by Local Excision Implant (NCT00977275) | Massachusetts General Hospital | 1997-06-01 |
| Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer (NCT00003042) | City of Hope Medical Center | 1997-05-30 |
| Combination Chemotherapy in Treating Patients With Metastatic Breast Cancer (NCT00006260) | Case Comprehensive Cancer Center | 1997-05-01 |
| A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among Women (NCT00342004) | National Cancer Institute (NCI) | 1997-05-01 |
| Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer (NCT00002967) | NSABP Foundation Inc | 1997-05-01 |
| Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer (NCT00002873) | Radiation Therapy Oncology Group | 1997-05-01 |
| High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer (NCT00003032) | NCIC Clinical Trials Group | 1997-04-25 |
| Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer (NCT00003050) | University of Southern California | 1997-04-01 |
| Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer (NCT00003035) | Georgetown University | 1997-03-01 |
| Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer (NCT00003086) | Louisiana State University Health Sciences Center Shreveport | 1997-03-01 |
| PET Scans in Patients With Locally Advanced Breast Cancer (NCT00109785) | Memorial Sloan Kettering Cancer Center | 1997-03-01 |
| Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast Cancer (NCT00590109) | Memorial Sloan Kettering Cancer Center | 1997-03-01 |
| S9630, Medroxyprogesterone in Treating Women With Breast Cancer (NCT00002920) | SWOG Cancer Research Network | 1997-03-01 |
| Spectroscopy With Surface Coils and Decoupling (NCT00581815) | Memorial Sloan Kettering Cancer Center | 1997-02-01 |
| Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer (NCT00003066) | Herbert Irving Comprehensive Cancer Center | 1997-02-01 |
| SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial (NCT00002900) | SWOG Cancer Research Network | 1997-02-01 |
| Biological Therapy in Treating Patients With Metastatic Cancer (NCT00004604) | Duke University | 1997-02-01 |
| Investigation of the Prognostic Value of Patterns of Genomic Alterations or Protein Expression in Patients With Operated Early Breast Cancer (NCT07630558) | Hellenic Cooperative Oncology Group | 1997-01-31 |
| Randomized Trial of Follow-up Strategies in Breast Cancer (NCT00156039) | Ontario Clinical Oncology Group (OCOG) | 1997-01-01 |
| Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery (NCT00015886) | Wake Forest University Health Sciences | 1997-01-01 |
| Pooled Analysis of Patients With Early-stage Breast Cancer Treated With Adjuvant Dose-dense Sequential Chemotherapy: a Hellenic Cooperative Oncology Group (HeCOG) Study. (NCT07521397) | Hellenic Cooperative Oncology Group | 1996-12-15 |
| Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast Cancer (NCT00002953) | Medical Research Council | 1996-12-01 |
| Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function (NCT00002901) | City of Hope Medical Center | 1996-12-01 |
| Adjuvant FEC Versus EP in Breast Cancer (MIG5) (NCT02450058) | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | 1996-11-01 |
| Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women. (NCT00287534) | AstraZeneca | 1996-11-01 |
| Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer (NCT00003012) | Scottish Cancer Therapy Network | 1996-10-01 |
| A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC) (NCT00152191) | Taiho Pharmaceutical Co., Ltd. | 1996-10-01 |
| Chemotherapy Plus Surgery in Treating Women With Breast Cancer (NCT00003013) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1996-10-01 |
| Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer (NCT00002864) | NCIC Clinical Trials Group | 1996-09-24 |
| Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease (NCT00001503) | National Cancer Institute (NCI) | 1996-09-19 |
| CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant (NCT00186680) | Stanford University | 1996-09-01 |
| Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394) (NCT00590785) | National Cancer Institute (NCI) | 1996-08-13 |
| Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer (NCT00002866) | NCIC Clinical Trials Group | 1996-08-12 |
| Vaccine Therapy in Treating Women With Metastatic Breast Cancer (NCT00003184) | Providence Cancer Center, Earle A. Chiles Research Institute | 1996-08-01 |
| Clinical Significance of Germline BRCA Mutations (NCT00579488) | Memorial Sloan Kettering Cancer Center | 1996-07-01 |
| S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer (NCT00002772) | SWOG Cancer Research Network | 1996-07-01 |
| The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC) (NCT00152178) | Taiho Pharmaceutical Co., Ltd. | 1996-07-01 |
| ATAC - Arimidex, Tamoxifen Alone or in Combination (NCT00849030) | AstraZeneca | 1996-07-01 |
| Lymph Node Radiation Therapy in Patients With Stage I, Stage II, or Stage III Breast Cancer That Has Been Surgically Removed (NCT00002851) | European Organisation for Research and Treatment of Cancer - EORTC | 1996-07-01 |
| Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer (NCT00002762) | Alliance for Clinical Trials in Oncology | 1996-06-01 |
| Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer (NCT00002937) | City of Hope Medical Center | 1996-06-01 |
| High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer (NCT00002784) | ETOP IBCSG Partners Foundation | 1996-06-01 |
| Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer (NCT00002942) | Wake Forest University Health Sciences | 1996-06-01 |
| Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer (NCT00002777) | European Organisation for Research and Treatment of Cancer - EORTC | 1996-05-01 |
| Molecular Analysis of Breast Cancer (NCT00569049) | Stanford University | 1996-05-01 |
| Biological Therapy in Treating Women With Metastatic Breast Cancer (NCT00002780) | St. Luke's Medical Center | 1996-05-01 |
| Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer (NCT00003099) | M.D. Anderson Cancer Center | 1996-05-01 |
| A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients (NCT00001504) | National Cancer Institute (NCI) | 1996-05-01 |
| Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer (NCT00008203) | Herbert Irving Comprehensive Cancer Center | 1996-05-01 |
| HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer (NCT00003002) | University of Washington | 1996-04-01 |
| Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer (NCT00003920) | University of California, Davis | 1996-04-01 |
| Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer (NCT00003577) | University Hospital Birmingham | 1996-03-01 |
| Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer (NCT00002668) | Eastern Cooperative Oncology Group | 1996-02-14 |
| Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer (NCT00019084) | National Cancer Institute (NCI) | 1996-02-01 |
| A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer (NCT00001498) | National Cancer Institute (NCI) | 1996-02-01 |
| Automated Tele Counseling for Screening Mammography (NCT00247013) | Boston Medical Center | 1996-01-01 |
| ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation. (NCT00291759) | AstraZeneca | 1996-01-01 |
| Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed (NCT00002707) | NSABP Foundation Inc | 1995-12-01 |
| Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast Cancer (NCT00002720) | European Institute of Oncology | 1995-12-01 |
| Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer (NCT00002755) | Scottish Cancer Therapy Network | 1995-11-01 |
| Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer (NCT00003016) | University of Oxford | 1995-10-01 |
| Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer (NCT00002646) | Eastern Cooperative Oncology Group | 1995-10-01 |
| Combination Chemotherapy in Treating Women With Stage III Breast Cancer (NCT00002696) | Grupo Oncologico Cooperativo del Sur | 1995-10-01 |
| A Follow-up Study of Women Evaluated and Treated for Infertility (NCT00342446) | National Cancer Institute (NCI) | 1995-10-01 |
| Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer (NCT00002836) | M.D. Anderson Cancer Center | 1995-09-26 |
| Surgical Breast Resection With or Without Axillary Lymph Node Excision in Treating Women With Breast Cancer (NCT00210236) | Institut Bergonié | 1995-09-01 |
| High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer (NCT00002837) | M.D. Anderson Cancer Center | 1995-09-01 |
| A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms (NCT00001444) | National Cancer Institute (NCI) | 1995-08-01 |
| Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers (NCT00608452) | Memorial Sloan Kettering Cancer Center | 1995-07-01 |
| Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer (NCT00005798) | H. Lee Moffitt Cancer Center and Research Institute | 1995-07-01 |
| Magnetic Resonance Imaging of Breast Cancer (NCT01035112) | Stanford University | 1995-04-01 |
| Women's Healthy Eating and Living Study (NCT00003787) | University of California, San Diego | 1995-03-01 |
| The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy (NCT00270166) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1995-02-01 |
| Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer (NCT00002616) | University of Illinois at Chicago | 1995-02-01 |
| High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer (NCT00002870) | UNICANCER | 1994-12-01 |
| Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer (NCT00002628) | St. Louis University | 1994-11-01 |
| Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer (NCT00002627) | St. Louis University | 1994-11-01 |
| Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas (NCT00019019) | National Institutes of Health Clinical Center (CC) | 1994-10-01 |
| Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer (NCT00002662) | Aventis Pharmaceuticals | 1994-08-01 |
| A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients (NCT00001384) | National Cancer Institute (NCI) | 1994-05-01 |
| Nutrition Intervention in Treating Women With Breast Cancer (NCT00002564) | Institute for Cancer Prevention (IFCP) | 1994-04-01 |
| A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 (NCT00001383) | National Cancer Institute (NCI) | 1994-03-01 |
| Pyrazoloacridine in Treating Women With Metastatic Breast Cancer (NCT00002585) | Barbara Ann Karmanos Cancer Institute | 1994-02-01 |
| Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer (NCT00002679) | Yale University | 1994-02-01 |
| Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer (NCT00002680) | Yale University | 1994-02-01 |
| Breast Cancer Surveillance Consortium (NCT01831778) | Kaiser Permanente | 1994-01-01 |
| A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer (NCT00001378) | National Cancer Institute (NCI) | 1994-01-01 |
| Tamoxifen for the Prevention of Breast Cancer in High-Risk Women (NCT00002644) | Queen Mary University of London | 1994-01-01 |
| Tamoxifen in Treating Women With High-Risk Breast Cancer (NCT00002542) | NCIC Clinical Trials Group | 1993-07-20 |
| Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer (NCT00002580) | Scottish Cancer Therapy Network | 1993-06-01 |
| Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer (NCT00002581) | Scottish Cancer Therapy Network | 1993-06-01 |
| Group Therapy for Primary Breast Cancer (NCT00220792) | Stanford University | 1993-06-01 |
| Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer (NCT00002582) | Institute of Cancer Research, United Kingdom | 1993-06-01 |
| Prognostic and Predictive Impact of uPA/PAI-1 (NCT01317108) | Universitätsklinikum Hamburg-Eppendorf | 1993-06-01 |
| Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer (NCT00002529) | ETOP IBCSG Partners Foundation | 1993-05-01 |
| Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast Cancer (NCT00002544) | Arbeitsgemeinschaft fur Internistische Onkologie | 1993-05-01 |
| Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer (NCT00002528) | ETOP IBCSG Partners Foundation | 1993-05-01 |
| Hypofractionated Radiotherapy Post-Lumpectomy in Women With Node Negative Breast Cancer (NCT00156052) | Ontario Clinical Oncology Group (OCOG) | 1993-04-01 |
| Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer (NCT00002579) | Scottish Cancer Therapy Network | 1993-03-01 |
| A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 (NCT00001302) | National Cancer Institute (NCI) | 1992-09-01 |